MOBI (Mobia Medical) Cash Conversion Cycle: 207.55 (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MOBI Mobia Medical Inc MOBI
7 GF Score
Price $11.05
! 1 Warning Sign
View Full Analysis

What is Mobia Medical Cash Conversion Cycle?

Mobia Medical MOBI -3.07% 7 Cash Conversion Cycle is 207.55 as of Dec. 2025. GuruFocus rates MOBI with a GF Score™ of 7/100. The stock has 1 warning sign investors should review.

Cash Conversion Cycle is one of several measures of management effectiveness. It equals Days Sales Outstanding + Days Inventory - Days Payable.

Mobia Medical's Days Sales Outstanding for the six months ended in Dec. 2025 was 41.36.
Mobia Medical's Days Inventory for the six months ended in Dec. 2025 was 267.34.
Mobia Medical's Days Payable for the six months ended in Dec. 2025 was 101.15.
Therefore, Mobia Medical's Cash Conversion Cycle (CCC) for the six months ended in Dec. 2025 was 207.55.


Mobia Medical  (NAS:MOBI) Cash Conversion Cycle Explanation

Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.


Be Aware

CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.

The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.


Mobia Medical Cash Conversion Cycle Related Terms


Mobia Medical Cash Conversion Cycle Historical Data

* Premium members only.

The historical data trend for Mobia Medical's Cash Conversion Cycle can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mobia Medical Cash Conversion Cycle Chart

Mobia Medical Annual Data
Trend Dec24 Dec25
Cash Conversion Cycle
327.72 207.55

Mobia Medical Semi-Annual Data
Dec24 Dec25
Cash Conversion Cycle 327.72 207.55

MOBI vs SI, PACB, KIDS: Cash Conversion Cycle Comparison

For the Medical Devices subindustry, Mobia Medical's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mobia Medical Cash Conversion Cycle vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Mobia Medical's Cash Conversion Cycle distribution charts can be found below:

* The bar in red indicates where Mobia Medical's Cash Conversion Cycle falls into.


MOBI
7GF Score
Mobia Medical Inc MOBI
Cash Conversion Cycle is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mobia Medical Cash Conversion Cycle Calculation

Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.

Cash Conversion Cycle is one of several measures of management effectiveness.

Mobia Medical's Cash Conversion Cycle for the fiscal year that ended in Dec. 2025 is calculated as

Cash Conversion Cycle=Days Sales Outstanding +Days Inventory-Days Payable
=41.36+267.34-101.15
=207.55

Mobia Medical's Cash Conversion Cycle for the quarter that ended in Dec. 2025 is calculated as:

Cash Conversion Cycle=Days Sales Outstanding+Days Inventory-Days Payable
=41.36+267.34-101.15
=207.55

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Cash Conversion Cycle →
What does a Cash Conversion Cycle of 207.55 mean?
Mobia Medical (MOBI) has a Cash Conversion Cycle of 207.55 as of Dec. 2025. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on Mobia Medical and its competitors.
Is Mobia Medical's Cash Conversion Cycle too high?
Mobia Medical's current Cash Conversion Cycle is 207.55. The Medical Devices & Instruments industry median Cash Conversion Cycle is 157.71. Mobia Medical's value of 207.55 is 31.6% above this industry median. Overall, Mobia Medical has a GF Score™ of 7/100, reflecting its overall financial health beyond just this single metric.
How does Mobia Medical's Cash Conversion Cycle compare to SI and PACB?
Mobia Medical's Cash Conversion Cycle of 207.55 can be compared against companies in the Medical Devices & Instruments industry. The industry median Cash Conversion Cycle is 157.71. Mobia Medical's value of 207.55 is 31.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Conversion Cycle for a Medical Devices & Instruments company?
The median Cash Conversion Cycle among Medical Devices & Instruments companies is 157.71, based on 818 companies in the industry. Companies in the top quartile (top 25%) have a Cash Conversion Cycle significantly above this median, while those in the bottom quartile fall well below. However, Cash Conversion Cycle should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mobia Medical's current Cash Conversion Cycle of 207.55 is 31.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Conversion Cycle mean?
A high Cash Conversion Cycle can signal that a stock is expensive relative to its fundamentals. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on Mobia Medical and its competitors. For the Medical Devices & Instruments industry, the median Cash Conversion Cycle is 157.71 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mobia Medical's current Cash Conversion Cycle is 207.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mobia Medical stock overvalued right now?
Mobia Medical (MOBI) has a current Cash Conversion Cycle of 207.55. The current Cash Conversion Cycle is 207.55 and 31.6% above the Medical Devices & Instruments industry median of 157.71. Mobia Medical's overall GF Score™ is 7/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Conversion Cycle calculated?
Cash Conversion Cycle is calculated from a company's financial statements. For Mobia Medical (MOBI), the current Cash Conversion Cycle is 207.55 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Mobia Medical Business Description

Address 2802 Flintrock Trace, Suite 226, Austin, TX, USA, 78738
Mobia Medical Inc is a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. The company develops, markets and sells devices for the treatment of medical conditions. Its flagship device is the Vivistim Paired Vagus Nerve Stimulation system, which is used to support motor function rehabilitation in patients with chronic ischemic stroke. The company generates all of its revenue from the sale of the Vivistim System to customers, mainly primary and comprehensive stroke centers, in the United States.
7GF Score

Get the complete analysis for MOBI

Cash Conversion Cycle is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$11.05
Price